수의약품 시장 규모, 점유율, 성장 분석 : 제품 유형별, 동물 종별, 투여 경로별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global Veterinary Medicine Market size was valued at USD 54.13 Billion in 2024 and is poised to grow from USD 58.84 Billion in 2025 to USD 114.69 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global veterinary medicine market is experiencing robust growth driven by rising demand for animal protein, increasing instances of zoonotic diseases, and the introduction of innovative products. Advancements in veterinary practices, coupled with a growing trend in pet insurance, further support this sector. The expansion of federally funded animal health and wellness programs enhances consumer access to essential services, bolstering animal welfare and ensuring food supply safety. These initiatives lead to the culling of zoonotic pathogens and promote sustainable farming practices. Regulatory frameworks established by governments ensure the effective approval, production, and distribution of veterinary drugs, vaccines, and feed additives while guaranteeing their safety, efficacy, and quality, thereby fostering consumer trust and confidence in animal health products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Medicine Market Segments Analysis

Global Veterinary Medicine Market is segmented by Product Type, Animal Type, Route of Administration, Distribution Channel and region. Based on Product Type, the market is segmented into Pharmaceuticals, Vaccines, Medicated Feed Additives & Supplements and Diagnostics & Services (supportive). Based on Animal Type, the market is segmented into Companion Animals (cats, dogs, pets), Production / Livestock Animals (cattle, swine, poultry, aquaculture) and Others. Based on Route of Administration, the market is segmented into Injectable, Oral (tablets, powders), Topical & Spot-On and Feed-Based Additives. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, Online Pharmacies and Feed Mill / Livestock Supply Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Medicine Market

The Global Veterinary Medicine market is being significantly driven by the rising costs associated with the development of specialty medicines, diagnostics, and preventive care. This trend stems from the growing humanization of pets, leading owners to invest more in their animals' health. As pets increasingly receive advanced treatment options, including vaccines, specialty medications, and wellness programs, there is a noticeable surge in demand for these products. In response, companies are compelled to innovate, creating biologics and palatable oral medications, as well as subscription-based care models. Such advancements not only enhance revenue per patient but also strengthen the connection between pet owners and veterinary professionals.

Restraints in the Global Veterinary Medicine Market

The Global Veterinary Medicine market faces significant restraints due to the rigorous regulatory requirements that biologics and veterinary medicines must navigate, with these regulations differing across nations. This complexity often leads to protracted trial periods for assessing safety and efficacy, consequently increasing development costs and lengthening the time required to bring products to market. Such regulatory uncertainties tend to disadvantage smaller enterprises, causing them to struggle in competitive environments and causing research and development efforts to remain concentrated within larger corporations. As a result, the introduction of innovative solutions, particularly in areas like gene therapy and alternative antibiotics, is impeded in both farms and clinical settings.

Market Trends of the Global Veterinary Medicine Market

The Global Veterinary Medicine market is experiencing a significant shift propelled by the integration of telehealth and digital technologies. Innovations such as telemedicine platforms, remote monitoring solutions, and AI-driven decision-support tools are transforming veterinary care delivery, particularly benefiting underserved rural populations through enhanced accessibility. Digital triage and e-prescribing facilitate more proactive health management, while synchronized clinical records with predictive analytics empower veterinarians to implement subscription-based care models. This approach not only bolsters compliance but also generates reliable revenue streams, improving herd health management and paving the way for a more sustainable and efficient veterinary practice landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Veterinary Medicine Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
• Vaccines
• Medicated Feed Additives & Supplements
• Diagnostics & Services (supportive)

Global Veterinary Medicine Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals (cats, dogs, pets)
• Production / Livestock Animals (cattle, swine, poultry, aquaculture)
• Others

Global Veterinary Medicine Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectable
• Oral (tablets, powders)
• Topical & Spot-On
• Feed-Based Additives

Global Veterinary Medicine Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Veterinary Pharmacies
• Online Pharmacies
• Feed Mill / Livestock Supply Channels

Global Veterinary Medicine Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (Merck & Co., Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Animal Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Animal Health division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuproxa (or others)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals plc (Animal Health)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Pharmaceuticals Ltd. (companion unit)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation (Veterinary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Biopharmaceuticals (Veterinary segment)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindred Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qilu Animal Health Company Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vland Bioengineering Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations